A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer

Clinical trial NCT07114315 · RECRUITING

Trial details

NCT number: NCT07114315
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2025-09-19
Primary completion: 2027-08-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.